The staphylococcus aureus peptidoglycan protects mice against the pathogen and eradicates experimentally induced infection

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Capparelli, Rosanna ^a   Nocerino, Nunzia ^a   Medaglia, Chiara ^a   Blaiotta, Giuseppe ^a   Bonelli, Patrizia ^b   Iannelli, Domenico ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

A170PG VACCINE; ADJUVANT; BACTERIAL VACCINE; PEPTIDOGLYCAN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; PEPTIDE FRAGMENT; RECOMBINANT VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; FEMALE; LISTERIA MONOCYTOGENES; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; SURVIVAL RATE; SYSTEMIC DISEASE; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; AFFINITY CHROMATOGRAPHY; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; HUMAN; IMMUNOLOGY; LUNG DISEASE; METABOLISM; MICROBIOLOGY; MORTALITY; PATHOGENICITY;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CHROMATOGRAPHY, AFFINITY; FEMALE; HUMANS; LUNG DISEASES; MICE; MICE, INBRED BALB C; PEPTIDE FRAGMENTS; PEPTIDOGLYCAN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, SYNTHETIC;

EID: 82455167220     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028377     Document Type: Article

References (31)

1. Liu G, (2009) Molecular pathogenesis of Staphylococcus aureus infection. Pediatric Res 65: 71R-77R.
2. Graham P, Lin S, Larson E, (2006) A U. S. population based survey of Staphylococcus aureus colonization. Annals of Internal Medicine 144: 318-325.
3. Kockritz-Blickweede M, Rodhe M, Oehmucke S, Miller L, Cheung A, et al. (2008) Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. Am J Path 173: 1657-1668.
4. Lorenz E, Mira J, Cornish K, Arbour N, Schwartz A, (2000) A novel polymorphism in the Toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 68: 6398-6401.
5. Moore C, Segal S, Berendt A, Hill A, Day N, (2004) Lack of association between Toll-like receptor 2 polymorphisms and susceptibility to severe diseases caused by Staphylococcus aureus. Clin Diagn Lab Immunol 11: 1194-1197.
6. Lowy FD, (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111: 1265-1273.
7. Boneca I, (2005) The role of peptidoglycan in pathogenesis. Curr Op Microbiol 8: 46-53.
8. Peterson P, Wilkinson B, Kim Y, Schmeling D, Douglas S, et al. (1978) The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest 61: 597-609.
9. Kowalski J, Berman D, (1971) Immunological activity of the cell wall antigens of Staphylococcus aureus. Infect Immun 4: 205-211.
10. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, et al. (1999) Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 274: 8405-8410.
11. Dziarki R, Gupta D, (2005) Staphylococcus aureus peptidoglycan is a Toll-like receptor 2 activator: a reevaluation. Infect Immun 73: 5212-5216.
12. Muller-Ansett M, Muller P, Albrecht T, Nega M, Wagener J, et al. (2010) Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes. PLoS ONE 5: 1-13.
13. Francius G, Domenech O, Mingeot-Leclerq M, Dufrene Y, (2008) Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin. J Bact 190: 7904-7909.
14. Wergeland H, Endresen C, (1987) Antibodies to various bacterial cell wall peptidoglycans in human and rabbit sera. J Clin Microbiol 25: 540-545.
15. Wergeland H, Haaheim L, Natas O, Wesenberg F, Oeding P, (1989) Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections. J Clin Microbiol 27: 1286-1291.
16. Fournier B, Philpott, (2005) Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 18: 521-540.
17. Wardenburg JB, Schneewind O, (2008) Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med 205: 287-294.
18. Marks M, (1990) Clinical significance of Staphylococcus aureus in cystic fibrosis. Infection 18: 53-56.
19. Schaffer A, Lee J, (2008) Vaccination and passive immunisation against Staphylococcus aureus. Int J Antimicrob Agents 325: S71-S78.
20. Holtfreter S, Kolota J, Broker B, (2010) Towards the immune proteome of Staphylococcus aureus- The anti-S. aureus antibody response. Int J Antimicrob Agents 300: 176-192.
21. Goodner K, Horsfall F, (1935) The protective action of type 1 antipneumococcus serum in mice. J Exp Med 62: 359-374.
22. Gantner B, Singh H, (2007) Short-term memory. Nature 447: 916-917.
23. Nau G, Richmond F, Schlesinger A, Jennings E, Lander E, et al. (2002) Human macrophage activation programs induced by bacterial pathogens. Proc Ntl Acad Sci 99: 1503-1508.
24. Blaiotta G, Pennacchia C, Ercolini D, Moschetti G, Villani F, (2003) Combining denaturing gradient gel electrophoresis of 16S-23S rDNA intergenic spacer region polymorphism analyses for the identification of staphylococci from Italian fermented sausages. Systematic Appl Microbiol 26: 423- 433.
25. Verdier I, Durand G, Bes M, Kimberley L, Lina G, et al. (2007) Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests. J Clin Microbiol 45: 725-729.
26. Blaiotta G, Ercolini D, Pennacchia C, Fusco V, Casaburi A, et al. (2004) PCR detection of staphylococcal enterotoxin genes in Staphylococcus spp. strains isolated from meat and dairy products. Evidence for new variants of seG and seI in S. aureus AB-8802. J Appl Microbiol 97: 719-730.
27. Blaiotta G, Fusco V, von Eiff G, Villani F, Becker K, (2006) Restriction nucleases analysis of the enterotoxin gene cluster (egc) polymorphism and spa typing analyses. Appl Environ Microbiol 72: 6117-6123.
28. Blaiotta G, Moschetti G, Simeoli E, Andolfi R, Villani F, et al. (2001) Monitoring lactic acid bacteria strains during "cacioricotta" cheese production by restriction endonucleases analysis and pulsed-field gel electrophoresis. J Dairy Res 68: 139-144.
29. Mellmann A, Friedrich AW, Rosenkotter N, Rothganger J, Karch H, et al. (2006) Automated DNA sequence-based early warning system for the detection of methicillin-resistant Staphylococcus aureus outbreaks. PLoS Med 3: e33.
30. Goding J, (1978) Use of the staphylococcal protein A as an immunological reagent. J Immun Meth 20: 241-253.
31. Capparelli R, Nocerino N, Iannaccone M, Ercolini D, Parlato M, et al. (2009) Phage therapy of Salmonella enterica: a fresh appraisal of phage therapy. J Infect Dis 201: 52: 52-61.